Marsh & Mclennan Companies, Inc. (MRSH) · Oct 15, 2026 · Earnings
Beat — Adjusted EPS $2.03 vs ~$1.97 consensus; revenue $6.863B vs ~$6.64B
Marsh’s Q3 earnings beat consensus on $2.03 adjusted EPS and $6.86B revenue, while litigation and weaker cash flow temper the headline.
Marsh is midway through a three-year Thrive transformation while combining insurance broking, reinsurance, employee benefits, investments, and management consulting under its new Marsh brand. The strategy is intended to improve growth and efficiency through operating-model changes, automation, data, and artificial intelligence.
The quarter beat a fairly modest market bar. Adjusted EPS was $2.03 versus published expectations clustered around $1.97, while revenue was $6.863 billion versus roughly $6.64 billion of consensus. That is a clear earnings beat, not merely a favorable presentation of year-over-year growth.
| Metric | Q3 2026 | Q3 2025 | Market comparison |
|---|---|---|---|
| Revenue | $6.863B | $6.351B | ~$6.64B consensus |
| Underlying revenue growth | 5% | — | ~3.9% consensus |
| GAAP diluted EPS | $1.69 | $1.51 | — |
| Adjusted EPS | $2.03 | $1.85 | ~$1.97 consensus |
| Operating income | $1.215B | $1.170B | — |
| Adjusted operating income | $1.527B | $1.439B | — |
| Operating cash flow, nine months | $2.313B | $3.131B | — |
The quality of growth was better than the headline 5% suggests. Management consulting delivered 14% underlying growth and total consulting grew 8%, while Risk grew 5% organically. That combination put underlying consolidated growth above the roughly 3.9% expectation and shows the transformation is producing momentum beyond acquisitions and currency.
Consulting is carrying more of the story, while reinsurance remains the weak spot. Management Consulting revenue rose 14% organically, but Reinsurance revenue fell 6% and Workforce and Rewards declined 1% on the same basis. Risk and Insurance Services grew only 3% underlying when fiduciary interest income is included, so the beat is not broad-based across every operating unit.
The adjusted result looks cleaner than GAAP profitability. Adjusted operating income rose 6% to $1.527 billion, but reported operating income rose only 4% to $1.215 billion, with $144 million of Greensill litigation expense, $30 million of legal costs, and $79 million of restructuring charges in the quarter. The adjusted operating margin held at 22.7%, exactly matching the prior-year figure, so this was primarily a growth and EPS beat rather than a margin-expansion quarter.
Capital returns remain aggressive, but cash conversion deteriorated. Marsh repurchased $500 million of stock in the quarter and $2.016 billion through nine months, helping support per-share growth as diluted shares fell to 479 million from 494 million. However, nine-month operating cash flow dropped to $2.313 billion from $3.131 billion, while the company issued $1.623 billion of commercial paper and $595 million of debt.
Bottom line: This was a genuine earnings beat driven by stronger-than-expected organic growth, especially in consulting, and meaningful buybacks. The business story improves, but flat adjusted margins, falling cash generation, and recurring legal and integration costs keep the quarter from being an unqualified acceleration.
Q3 earnings call, October 15
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!